Influences of angiogenesis and lymphangiogenesis on cancerous invasion in experimentally induced tongue carcinoma

Journal of Oral Pathology and Medicine

Volumn 34, Issue 2, 2005, Pages 87-92

  Nakaya, Hiromitsu ^a   Kawashiri, Shuichi ^a   Tanaka, Akira ^a   Noguchi, Natsuyo ^a   Kato, Koroku ^a   Hase, Takashi ^a   Yamamoto, Etsuhide ^a  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Angiogenesis; Experimentally induced tongue carcinoma; Lymphangiogenesis; Mode of cancer invasion; Vessels density

Indexed keywords

ACETONE; ANAZOLENE SODIUM; DIMETHYLBENZ[A]ANTHRACENE; VASCULOTROPIN C;

ADVANCED CANCER; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER MODEL; DENSITY; FROZEN SECTION; LYMPH VESSEL; LYMPHANGIOGENESIS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; STAINING; SYRIAN HAMSTER; TONGUE CARCINOMA;

9,10-DIMETHYL-1,2-BENZANTHRACENE; ANIMALS; CARCINOGENS; CRICETINAE; LYMPHANGIOGENESIS; MALE; MESOCRICETUS; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; TONGUE NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

EID: 12444276601     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2004.00279.x     Document Type: Article

References (28)

1. Folkman J. Tumor angiogenesis. Adv Cancer Res 1985; 43: 175-203.
2. Smith BD, Smith GL. Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma. J Clin Oncol 2000; 18: 2046-52.
3. Gasparini G. Prognostic value of vascular endothelial growth factor in breast cancer. Oncologist 2000; 5: 37-44.
4. Kaipainen A, Korhonen J, Mustonen T. Expression of the FMS-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995; 92: 3566-70.
5. Yonemura Y, Endo Y, Fujita H, Fushida S. Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin Cancer Res 1999; 5: 1823-9.
6. Tsurusaki T, Kanda S, Sasaki H, Kanetake H, Saito Y, Alitalo K. Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis. Br J Cancer 1999; 80: 309-13.
7. Akagi K, Ikeda Y, Miyazaki M, Abe T, Kinoshita J, Maehara Y. Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues. Br J Cancer 2000; 83: 887-91.
8. Niki T, Ibe S, Tokunou M, Yamada T, Matsuno Y, Hirohashi S. Expression of vascular endothelial growth factors A, B, C and D and their relationships to lymph node status in lung adenocarcinoma. Clin Cancer Res 2000; 6: 2431-9.
9. Hashimoto I, Kodama J, Seki N, Hongo A, Yoshinouchi M, Okuda H. Vascular endothelial growth factor-C expression and its relationship to pelvic lymph node status in invasion cervical cancer. Br J Cancer 2001; 85: 93-7.
10. Kitadai Y, Amioka T, Haruma K, Tanaka S, Yoshihara M, Sumii K. Clinicopathological significance of vascular endothelial growth factor (VEGF-C) in human esophageal squamous cell carcinomas. Int J Cancer 2001; 93: 662-6.
11. Skobe M, Hawighorst T, Jackson DG. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192-8.
12. Yamamoto E, Kohama G, Sunakawa H, Iwai M, Hiratsuka H. Mode of invasion, and lymph node metastasis in squamous cell carcinoma of oral cavity. Cancer 1983; 51: 2175-80.
13. Yamamoto E, Kohama G, Hiratsuka H, Kumagai S. Role of preoperative chemotherapy for oral cancer from the viewpoint of mode of invasion. Asian J Oral Maxillofac Surg 1994; 6: 113-21.
14. Fujita K, Kaku T, Sasaki M, Onoe T. Experimental production of lingual carcinoma in hamsters by local application of 9,10-dimethyl-1,2-benzanthracene. J Dent Res 1973; 52: 327-32.
15. Kato S, Miyauchi R. Enzyme-histochemical visualization of lymphatic capillaries in the mouse tongue: light and electron microscopic study. Okajimas Fol Anat Jpn 1989; 65: 391-404.
16. Kato S. Histochemical localization of 5′-nucleotidase in the lymphatic endothelium. Acta Histochem Cytochem 1990; 23: 613-20.
17. Zimmermann H. 5′-Nucleotidase: molecular structure and functional aspects. Biochem J 1992; 285: 345-65.
18. Mori K. Identification of lymphatic vessels after intraarterial injection of dyes and other substances. Microvasc Res 1969; 1: 268-74.
19. Williams JK, Calson GW, Cohen C. Tumor angiogenesis as a prognostic factor in oral cavity tumors. Am J Surg 1994; 168: 373-80.
20. Gleich LL, Biddinger PW, Duperier FD. Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical-pathologic correlation. Head Neck 1997; 19: 276-80.
21. Dumont AE. Factor VIII-related antigen. J Nat Cancer Inst 1993; 85: 674-6.
22. Folkman J. Angiogenesis and tumor growth. N Engl J Med 1996; 334: 920-1.
23. Ebata N, Nodasaka Y. Desmoplakin as a specific marker of lymphatic vessels. Microvasc Res 2001; 61: 40-8.
24. Banerji S, Ni J, Wang S, Clasper S, Su J. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor hyaluronan. J Cell Biol 1999; 144: 789-801.
25. Maula SM, Luukkaa M, Grénman R, Jackson D. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region. Cancer Res 2003; 63: 1920-6.
26. Kishimoto K, Sasaki A, Yoshihama Y, Mese H. Expression of vascular endothelial growth factor-C predicts regional lymph node metastasis in early oral squamous cell carcinoma. Oral Oncol 2003; 39: 391-6.
27. Noguchi N, Kawashiri S, Tanaka A, Kato K, Nakaya H. Effect of fibroblast growth inhibitor on proliferation and metastasis of oral squamous cell carcinoma. Oral Oncol 2003; 39: 240-7.
28. Ueda N, Kamata N, Hayashi E, Yokoyama K, Hoteiya T, Nagayama M. Effects of an anti-angiogenic agent, TNP-470, on the growth of oral squamous cell carcinomas. Oral Oncol 1999; 35: 554-60.